Updated:
TransPacific Venture Partners
TPV is an Asia-based venture capital that actively assesses and invests in early stage medical technology ventures. Our partners have years of experience in...
TransPacific Venture Partners
TPV is an Asia-based venture capital that actively assesses and invests in early stage medical technology ventures. Our partners have years of experience in the fields of medicine, engineering, venture investing and founding start-ups.
General information
Firm type
Venture Capital
Location
Region
Asia
Country
Taiwan
City
Taipei City
Corporate office
Taipei City, Taiwan
Frequently asked questions
What is TransPacific Venture Partners' core investment thesis?
TransPacific invests in early-stage companies that benefit from physical proximity to Asian supply chains and manufacturing networks. The firm believes startups with hardware or operational dependencies can gain a material speed and cost advantage by building within Taiwan's semiconductor and contract-manufacturing ecosystem.
Which sectors does TransPacific Venture Partners target?
The firm focuses on hardware-enabled technology, deep tech, industrial technology, and robotics—sectors where Asian supply-chain integration directly affects time-to-market and unit economics. It also evaluates software-enabled businesses that require regional go-to-market support.
Does TransPacific invest only in Taiwanese companies?
No. While the firm is based in Taipei, its mandate is cross-border—it invests in North American and broader Asia-Pacific companies that can use Taiwan as an operational and manufacturing base. The portfolio typically blends companies with founders in both regions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: